Lexicon Pharmaceuticals I... (LXRX)
NASDAQ: LXRX
· Real-Time Price · USD
0.68
-0.02 (-3.00%)
At close: May 12, 2025, 3:59 PM
0.69
2.20%
After-hours: May 12, 2025, 05:22 PM EDT
Lexicon Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Reportable Segment Revenue | 31.08M |
| Reportable Segment Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 32.26M | 39.59M | 39.19M | 32.06M | 32.61M | 32.23M | 30.01M | 19.14M | 16.33M | 12.58M | 10.69M | 8.49M | 8.85M | 7.3M | 7.94M | 8.26M | 6.43M | 12M | 14.11M | 14.69M | 14.56M | 13.9M | 14.26M | 14.11M | 16.56M | 15.58M | 16.75M | 14.86M | 16.13M | 16.72M | 18.48M | 14.87M | 13.97M | 12.26M | 8.42M | 8.4M | 6.45M | 5.38M | 6.31M | 5.7M |
| Selling, General, and Administrative Revenue Growth | -18.52% | +1.02% | +22.25% | -1.68% | +1.18% | +7.40% | +56.78% | +17.21% | +29.83% | +17.70% | +25.85% | -4.01% | +21.13% | -7.98% | -3.89% | +28.37% | -46.39% | -14.99% | -3.91% | +0.85% | +4.79% | -2.56% | +1.08% | -14.81% | +6.32% | -7.02% | +12.78% | -7.91% | -3.53% | -9.48% | +24.24% | +6.47% | +13.90% | +45.71% | +0.21% | +30.24% | +19.87% | -14.71% | +10.63% | n/a |
| Research and Development Revenue | 26.68M | 25.78M | 17.64M | 14.23M | 14.62M | 17.56M | 14.54M | 12.03M | 13.98M | 10.56M | 13.36M | 14.93M | 16.5M | 15.68M | 10.26M | 12.61M | 992K | 40.15M | 57.3M | 55.18M | 40.61M | 26.66M | 12.64M | 12.02M | 12.31M | 13.77M | 26.59M | 47.78M | 47.16M | 39.14M | 26.93M | 43.58M | 40.4M | 52.53M | 48.22M | 37M | 30.44M | 23.11M | 20.77M | 20.86M |
| Research and Development Revenue Growth | +3.51% | +46.12% | +24.00% | -2.65% | -16.76% | +20.75% | +20.91% | -13.96% | +32.40% | -20.96% | -10.52% | -9.53% | +5.20% | +52.89% | -18.65% | +1171.07% | -97.53% | -29.94% | +3.84% | +35.89% | +52.32% | +110.96% | +5.12% | -2.31% | -10.63% | -48.22% | -44.35% | +1.32% | +20.50% | +45.31% | -38.20% | +7.87% | -23.10% | +8.95% | +30.31% | +21.55% | +31.72% | +11.28% | -0.46% | n/a |